Skip to main content

Think twice before investing in biotech companies working on coronavirus treatments — ‘the odds of picking a winner are low’

The companies won’t make a lot of money even if they are successful, says Michael Brush.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.